Walleye Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Walleye Trading’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,000	Closed	-$129K	–	4117
2025 Q4	$129K	Buy	+6,000	New	+$116K	﹤0.01%	3625
2025 Q2	–	Sell	-3,900	Closed	-$30.5K	–	4213
2025 Q1	$30.5K	Buy	+3,900	New	+$32.7K	﹤0.01%	3724
2022 Q2	–	Sell	-100	Closed	-$1K	–	5104
2022 Q1	$1K	Buy	+100	New	+$687	﹤0.01%	5223
2021 Q2	–	Sell	-2,400	Closed	-$22K	–	5132
2021 Q1	$22K	Sell	2,400 -18,700	-89%	-$151K	﹤0.01%	4527
2020 Q4	$141K	Buy	+21,100	New	+$132K	﹤0.01%	3739
2020 Q2	–	Sell	-3,800	Closed	-$30K	–	4223
2020 Q1	$30K	Hold	3,800	–	–	﹤0.01%	3540
2019 Q4	$29K	Buy	+3,800	New	+$20.1K	﹤0.01%	3927

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's AVDL Position: Q1 2020 in Review

Walleye Trading sold out of Avadel Pharmaceuticals (AVDL) in Q1 2020, closing a stake of 4,154 shares — an estimated $31.9K sold.

Walleye Trading first reported a position in AVDL in Q3 2015 and held it in 11 quarters. The position peaked at $165K in Q3 2016. 56 funds tracked by Wall St. Rank hold AVDL as of Q1 2020.

Walleye Trading reported no remaining Avadel Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Walleye Trading sold 4,154 Avadel Pharmaceuticals shares in Q1 2020, an estimated $31.9K.
Walleye Trading first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 11 quarters.
Walleye Trading's Avadel Pharmaceuticals position peaked at $165K in Q3 2016.
56 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.